Casdin Capital, LLC Top Holdings and 13F Report (2021) About Casdin Capital, LLCInvestment ActivityCasdin Capital, LLC has $1.50 billion in total holdings as of September 30, 2021.Casdin Capital, LLC owns shares of 35 different stocks, but just 11 companies or ETFs make up 80% of its holdings.Approximately 6.70% of the portfolio was purchased this quarter.About 3.10% of the portfolio was sold this quarter.This quarter, Casdin Capital, LLC has purchased 38 new stocks and bought additional shares in 11 stocks.Casdin Capital, LLC sold shares of 5 stocks and completely divested from 4 stocks this quarter.Largest Holdings BioLife Solutions $218,027,412Revolution Medicines $186,582,734GeneDx $148,844,040Standard BioTools $137,521,527Sarepta Therapeutics $134,069,415 Largest New Holdings this Quarter GINKGO BIOWORKS HOLDINGS INC $297,418 Holding Largest Purchases this Quarter Illumina 270,000 shares (about $35.21M)Codexis 6,100,000 shares (about $18.79M)Standard BioTools 7,295,000 shares (about $14.08M)Syndax Pharmaceuticals 325,000 shares (about $6.26M)Guardant Health 250,000 shares (about $5.74M) Largest Sales this Quarter Revolution Medicines 292,592 shares (about $13.27M)Denali Therapeutics 310,000 shares (about $9.03M)Veracyte 191,596 shares (about $6.52M)Monte Rosa Therapeutics 175,000 shares (about $927.50K)GeneDx 19,247 shares (about $816.84K) Sector Allocation Over TimeMap of 500 Largest Holdings ofCasdin Capital, LLC Selling Neutral Buying Latest 13F Holdings and Changes Since Previous Quarterly FilingIssuer NameHoldings ValueApproximate Purchase/SaleChange in SharesShares Held% of PortfolioSectorBLFSBioLife Solutions$218,027,4120.0%8,707,16514.5%MedicalRVMDRevolution Medicines$186,582,734$13,269,047 ▼-6.6%4,114,28312.4%MedicalWGSGeneDx$148,844,040$816,843 ▼-0.5%3,507,1649.9%MedicalLABStandard BioTools$137,521,527$14,079,350 ▲11.4%71,254,6779.2%MedicalSRPTSarepta Therapeutics$134,069,4150.0%1,073,5008.9%MedicalILMNIllumina$97,807,500$35,210,700 ▲56.3%750,0006.5%MedicalRNAAvidity Biosciences$95,756,7470.0%2,084,8416.4%MedicalRLAYRelay Therapeutics$65,497,845$5,681,941 ▲9.5%9,251,1084.4%MedicalALNYAlnylam Pharmaceuticals$46,755,1000.0%170,0003.1%MedicalEXASExact Sciences$44,278,0000.0%650,0003.0%MedicalNTLAIntellia Therapeutics$41,100,0000.0%2,000,0002.7%MedicalGPCRStructure Therapeutics$30,723,0000.0%700,0002.0%MedicalBPMCBlueprint Medicines$30,189,9650.0%326,3782.0%MedicalDNLIDenali Therapeutics$28,838,700$9,030,300 ▼-23.8%990,0001.9%MedicalCDXSCodexis$24,948,000$18,788,000 ▲305.0%8,100,0001.7%MedicalVCYTVeracyte$22,681,124$6,521,928 ▼-22.3%666,3081.5%MedicalNEUROGENE INC$22,012,8870.0%524,6161.5%COMVERVVerve Therapeutics$19,338,564$4,532,549 ▲30.6%3,995,5711.3%MedicalBEAMBeam Therapeutics$18,987,500$2,450,000 ▲14.8%775,0001.3%MedicalTNYATenaya Therapeutics$12,994,6340.0%6,732,9710.9%MedicalFDMT4D Molecular Therapeutics$12,431,500$3,783,500 ▲43.8%1,150,0000.8%MedicalTSVT2seventy bio$9,440,0000.0%2,000,0000.6%MedicalTNGXTango Therapeutics$9,150,2870.0%1,188,3490.6%MedicalSNDXSyndax Pharmaceuticals$9,143,750$6,256,250 ▲216.7%475,0000.6%MedicalGHGuardant Health$8,029,000$5,735,000 ▲250.0%350,0000.5%MedicalCONTINEUM THERAPEUTICS INC$5,678,1870.0%296,6660.4%CL AIPSCCentury Therapeutics$5,493,060$10,151 ▲0.2%3,212,3160.4%MedicalGRAIL INC$4,816,000$3,715,214 ▲337.5%350,0000.3%COMABSIAbsci$3,717,8530.0%973,2600.2%MedicalPACBPacific Biosciences of California$1,760,9600.0%1,035,8590.1%MedicalPRMEPrime Medicine$1,420,9670.0%367,1750.1%MedicalEXAIExscientia$1,043,8320.0%213,9000.1%MedicalGLUEMonte Rosa Therapeutics$455,874$927,500 ▼-67.0%86,0140.0%MedicalGINKGO BIOWORKS HOLDINGS INC$297,418$297,418 ▲New Holding36,4930.0%CL A NEWKRONKronos Bio$123,8270.0%123,8390.0%MedicalPLRXPliant Therapeutics$0$10,750,000 ▼-100.0%00.0%MedicalKYVERNA THERAPEUTICS INC$0$4,312,500 ▼-100.0%00.0%COMDNAGinkgo Bioworks$0$487,993 ▼-100.0%00.0%MedicalSINGULAR GENOMICS SYSTEMS IN$0$372,890 ▼-100.0%00.0%COM NEWShowing largest 100 holdings. View all holdings. More Institutional Buying and Selling Information SEC Filings and Trading Data SEC Filings 13F Filings Top 13F Buys Top 13F Sells Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
